(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
I read 115 books this year. 'Wuthering Heights,' 'Heart the Lover' and 'The House of My Mother' were among my 10 favorites. - 2IDF strikes Tehran command centers, weapon production sites
- 3Israel halts defense sales to France, citing 'hostile attitude,' sources tell 'Post'
- 4Roman around the Christmas tree | Space photo of the day for Dec. 25, 2025
- 510 Energizing Vocations in the Innovation Business
- Germany's Lufthansa enters race for stake in Portuguese airline TAP
- The 10 Most Famous Style Minutes on Honorary pathway
- They died 'doing what they loved': The stories of workers in their 80s who died on the job
- Kobe Bryant called this WNBA star the 'Gold Mamba.' She turned his advice to her into a tattoo.
- Scientists Just Discovered Japan’s First New Bird Species in Over 40 Years
- These four astronauts could soon travel farther from Earth than anyone has gone before
- Germany unveils rescue plan for struggling chemical sector
- ‘Slender Man’ attacker back in custody. What we know about Morgan Geyser's disappearance and what happens next.
- French ship crosses Strait of Hormuz in first Western European transit during Iran war
